Share:
SHANNON, Ireland, May 04, 2021 (GLOBE NEWSWIRE) -- PBC Biomed, an Irish-based Medical Device Company, will lead a consortium comprised of Biodesign Europe and SFI Research Centre for Advanced Manufacturing (I-Form) at Dublin City University and Dolmen Design & Innovation, a Dublin-based product design company, in developing a bone adhesive for the treatment of osteoporotic fractures. This partnership was recently awarded €3.4M by the Irish Governments Disruptive Technologies Innovation Fund (DTIF), with an additional €2M investment from the industry partners associated with the project.
PBC Biomed, located in Shannon with a US office in Memphis, Tennessee, is focused on accelerating medical innovation in the areas of bone and tissue healing through partnerships with healthcare professionals, academic institutions and medtech companies. The development of a bone adhesive that will significantly reduce operating times, risk of infection, and the need for hardware in complex fracture treatment has the potential to significantly disrupt the standard of care. The DTIF award will support the expansion of this technology into other clinical applications, such as tissue regeneration and repair.